menu
    • menu

    Company profile for Serum Institute of India

    NEW Drugs in Dev: 29
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Serum Institute of India Ltd. has established it's self as the world's largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine manufactured by Serum Institute. In fact, our range of products have been used in 140 countries across the globe. Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving...
    Serum Institute of India Ltd. has established it's self as the world's largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine manufactured by Serum Institute. In fact, our range of products have been used in 140 countries across the globe. Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Serum Institute of Indiaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    212/2, Hadapsar, Off Soli Poonawalla Road, Pune-411028. Indi
    Telephone
    Telephone
    91-20-26993900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.seruminstitute.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oxford, Serum Institute Ink New Malaria Vaccine Pact
    Oxford, Serum Institute Ink New Malaria Vaccine Pact

    29 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/oxford-university-strikes-new-malaria-vaccine-pact-with-serum-institute-of-india/articleshow/130589655.cms

    ECONOMICTIMES
    29 Apr 2026
    Share Share
    Poonawalla's Clear Shot: Universal Access via Route Social
    Poonawalla's Clear Shot: Universal Access via Route Social

    17 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/poonawallas-clear-shot-at-access-for-all-via-route-social/articleshow/130317107.cms

    ECONOMICTIMES
    17 Apr 2026
    Share Share
    Poonawalla's clear shot at access for all via route social
    Poonawalla's clear shot at access for all via route social

    17 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/poonawallas-clear-shot-at-access-for-all-via-route-social/articleshow/130317107.cms

    ECONOMICTIMES
    17 Apr 2026
    Share Share
    Poonawalla Urges Funding for Innovations to Retain India's
    Poonawalla Urges Funding for Innovations to Retain India's

    16 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/funding-for-innovations-key-for-india-to-remain-vaccine-leader-cyrus-poonawalla/articleshow/130292992.cms

    ECONOMICTIMES
    16 Apr 2026
    Share Share
    Valneva, Serum Institute End Chikungunya Vaccine License Deal
    Valneva, Serum Institute End Chikungunya Vaccine License Deal

    31 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/31/3211836/0/en/Valneva-and-Serum-Institute-of-India-Announce-Discontinuation-of-Chikungunya-Vaccine-License-Agreement.html

    GLOBENEWSWIRE
    31 Dec 2025
    Share Share
    NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine
    NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine

    29 Dec 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183276&sid=1

    PHARMABIZ
    29 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search